|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41,700.00 VND | -0.24% |
|
-0.24% | -20.57% |
| 07-01 | Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026 | CI |
| 06-30 | Imexpharm Corporation Announces Management Appointments | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.24% | -0.24% | -8.95% | -25.00% | -20.57% | -20.11% | +50.75% | +28.78% | +207.59% | 245M | |
| -1.60% | +2.02% | +5.80% | +27.54% | +13.13% | +56.34% | +168.94% | +412.75% | +1,426.27% | 1,102B | |
| -1.44% | +3.71% | +13.46% | +9.16% | +27.28% | +69.07% | +65.40% | +55.78% | +114.41% | 643B | |
| -0.75% | +0.67% | +13.30% | +19.45% | +10.61% | +33.18% | +86.52% | +117.22% | +293.92% | 450B | |
| -1.35% | +1.86% | +3.78% | +6.62% | +2.04% | +29.96% | +26.28% | -5.38% | +31.59% | 336B | |
| -0.86% | +2.79% | +3.22% | -6.41% | +3.26% | +37.72% | +40.85% | +65.79% | +211.32% | 298B | |
| -0.71% | +0.72% | +7.30% | +3.90% | +14.87% | +28.85% | +48.27% | +49.68% | +55.82% | 288B | |
| -1.31% | -0.26% | +18.81% | +34.59% | -0.65% | -28.18% | -39.82% | +19.20% | +76.01% | 222B | |
| -0.03% | +1.84% | +6.44% | +5.20% | +12.43% | +23.90% | +68.30% | +50.64% | +128.42% | 199B | |
| -0.40% | +7.82% | +6.03% | -4.04% | +10.66% | +22.29% | +82.50% | +100.65% | +56.93% | 169B | |
| -0.08% | +0.71% | -6.13% | -12.45% | -3.41% | -6.13% | -32.31% | -38.73% | -33.42% | 137B | |
| -4.56% | +0.08% | +12.52% | +12.28% | +9.94% | +6.88% | +47.39% | +152.06% | +460.29% | 133B | |
| -0.74% | +1.95% | +3.55% | -2.80% | +6.67% | +22.32% | -8.16% | -13.72% | -23.57% | 118B | |
| -1.17% | +2.56% | +3.48% | -6.85% | +8.50% | +39.99% | +50.42% | +11.05% | -4.17% | 107B | |
| -0.54% | +3.18% | -1.70% | -6.80% | -8.89% | -9.55% | -19.78% | -12.14% | +1.59% | 104B | |
| +0.48% | -0.57% | +0.03% | -15.92% | -10.49% | +8.40% | +92.74% | +78.90% | +482.47% | 77.46B | |
| -2.32% | +1.31% | +39.09% | +22.63% | +34.13% | +82.63% | +1.80% | -1.90% | -45.40% | 57.05B | |
| -2.44% | +0.43% | +17.57% | -5.99% | -9.33% | +1.14% | +11.61% | -11.99% | +258.96% | 53.81B | |
| -0.92% | +2.46% | +8.62% | -7.16% | +11.77% | +21.99% | +22.60% | +48.30% | +23.29% | 53.16B | |
| -0.52% | +3.71% | +9.82% | -1.46% | -3.01% | -2.07% | +17.71% | - | - | 43.09B | |
| Average | -1.07% | +2.28% | +7.80% | +2.32% | +5.45% | +20.93% | +39.10% | +58.26% | +195.91% | 229.48B | |
| Weighted average by Cap. | -1.20% | +2.54% | +8.13% | +11.30% | +10.81% | +36.13% | +72.96% | +138.11% | +444.80% |
- Stock Market
- Stocks
- IMP Stock
- Sector Imexpharm Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
